FORMER CO-CEO OF OMNI ORAL PHARMACEUTICALS JOINS GOODMOUTH ADVISORY BOARD

JENNIFER JACKSON, FORMER CO-CEO OF OMNI ORAL PHARMACEUTICALS (NOW A 3M COMPANY), AND FOUNDER OF JOURNEY PEROFRMANCE GROUP, JOINS GOODMOUTH ADVISORY BOARD

New Version of CAESY Cloud Features Interactive 3D Animations, 3D models and

E-mail Capability

January 15 — GoodMouth is pleased to announce that Jennifer Jackson, former Co-Owner and CEO of OMNI Oral Pharmaceuticals, and founder of Journey Performance Group, has joined its Advisory Board.

“Our advisory board exists to bring together the most innovative and resourceful executives to support GoodMouth’s aim of delivering exceptional subscriber experiences. Jennifer is a proven leader in preventive dentistry and has an extraordinary commitment to customer service excellence. We are thrilled to have her as part of our team,” explains Craig Lifschutz, GoodMouth’s Founder and CEO.

“It is inspiring to be a part of an innovative company that will enhance oral health, recall rates and patient retention – All while giving back to those in need – GoodMouth is the future, delivered today,” explains Jennifer Jackson.

About Jennifer Jackson

Jennifer Jackson, founder of Journey Performance Group, has over 25 years of leadership experience in sales force development and training. She has led numerous sales team integration initiatives through effective management coaching, sales process development and team building. Her extensive relationships with dental industry and academic leaders are a result of her passion and dedication to the profession. Jennifer was an owner and co-CEO of OMNI Oral Pharmaceuticals, prior to its acquisition by 3M Company. She was instrumental in the successful integration of the two companies’ 150 plus person sales teams prior to founding Journey Performance Group. Jennifer has also held positions in sales, national account management and private label product development with Dentsply International.

# # #